Vanderbilt mourns loss of physician-scientist van Eys
Sep. 26, 2022—Jan van Eys, MD, PhD, clinical professor of Pediatrics, emeritus, died Sept. 24.
Morton to help lead blood disorders treatment efforts
Jan. 12, 2017—Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer.
Vanderbilt University honors 28 as emeriti faculty
May. 8, 2015—Twenty-eight retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 8, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty.
HER2 may impact lung cancer therapy
Sep. 21, 2012—A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.
Targeting post-transplant diabetes
Apr. 12, 2012—Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
‘Detangler’ binds, bends and cuts DNA
Mar. 2, 2012—New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.
Averting a future oncologist shortage
Nov. 11, 2011—Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists.